Gonorrhea

“Gonorrhea Alert” Intensifies Globally, says AHF

Retrieved on: 
Wednesday, July 26, 2023
Public Policy, Government, Pharmaceutical, AIDS, Health, Infectious Diseases, Communications, Social Activism, Advocacy Group Opinion, Infection, AHF, STI, Neisseria gonorrhoeae, Gonorrhea, Multimedia, HIV, AIDS Healthcare Foundation, Syphilis, World Health Organization, Disease, Vaccine, Birth control, Neisseria

Neisseria gonorrhea is exceptionally dangerous due to its resistance to multiple treatments, including new antibiotics being developed specifically for this pathogen.

Key Points: 
  • Neisseria gonorrhea is exceptionally dangerous due to its resistance to multiple treatments, including new antibiotics being developed specifically for this pathogen.
  • “Condoms are still the most cost-effective way to prevent gonorrhea, syphilis, and other STIs, including HIV – a fact people everywhere should be made aware of.
  • That starts with information campaigns at all levels of government in all countries and ensuring adequate access to free or affordable condoms.
  • Over 82 million new cases of Neisseria gonorrhea are reported in adults between the ages of 15 to 49 annually, according to the World Health Organization.

STIs are on the rise – here's how to navigate telling a partner if you've got one

Retrieved on: 
Tuesday, July 25, 2023
Vaccine, Infection, Contact tracing, Pregnancy, Life, HIV, STI, Friends, Education, Method, Public, Policy, Disclosure, Trichomoniasis, Taboo, World, Woman, Infertility, Guilt, Research, GP, COVID, Life expectancy, Language, Partner (business rank), Embarrassment, Gonorrhea, Shame, Man, Human, Risk, Cancer, Use-centered design, Quarterlife, Miscarriage, Stillbirth, Chlamydia, Diagnosis, Condom, NHS, Health, Mental health, Family, News, Syphilis, World Health Organization, Disease, Pharmaceutical industry, Birth control, Nursing, Online shopping

The number of gonorrhoea diagnoses recorded in England was in fact the highest since annual records began.

Key Points: 
  • The number of gonorrhoea diagnoses recorded in England was in fact the highest since annual records began.
  • On one hand you are being honest, responsible and respectful to your partner (or partners), and protecting their health.
  • The articles in this series explore the questions and bring answers as we navigate this turbulent period of life.
  • Letting sexual partners know if you have an STI is essential to the prevention, treatment and control of these infections.

Honesty is the best policy

    • For example, a single course of antibiotics will often clear chlamydia, gonorrhoea, syphilis and “trich” (trichomoniasis).
    • It’s totally normal to be anxious about your partner’s response and the potential effect on your relationship, whether casual or long term.
    • It’s also important to disclose if you have an STI before starting a sexual relationship with someone new.

What if a partner discloses that they have an STI?

    • When asking these questions, try to be mindful of the language you use, and avoid placing blame.
    • An early STI diagnosis is the best opportunity for effective treatment, and prevention of health complications and further transmission.
    • If you do decide to have sex, it’s advisable to use a physical barrier such as a condom or dental dam to protect your partner.

Make this an opportunity

    • Whether it’s you or your partner who have an STI – or both – use this opportunity to do some research on sexual health.
    • The COVID pandemic has also shown us the crucial role of early detection, rapid testing, and importantly, public health communication and education.
    • Overcoming STI stigma, much like COVID stigma, requires education, improving access to STI testing and treatment, and the promotion of inclusive conversations about sexual health.

FDA Approves First Nonprescription Daily Oral Contraceptive

Retrieved on: 
Thursday, July 13, 2023
Vaginal bleeding, Pregnancy, Headache, Syphilis, Laboratoires Pierre Fabre, Bleeding, HIV, Center for Drug Evaluation and Research, Prenatal care, Condom, Cancer, Gonorrhea, Cramp, Hepatitis B, Perrigo, Appetite, Abdominal pain, Dizziness, AIDS, Wart, Risk, Child, Norgestrel, Genital herpes, Vertically transmitted infection, Nausea, Bloating, Chlamydia, Amenorrhea, Research, FDA, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Breast cancer, Birth control, Pharmaceutical industry

Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stores, convenience stores and grocery stores, as well as online.

Key Points: 
  • Approval of this progestin-only oral contraceptive pill provides an option for consumers to purchase oral contraceptive medicine without a prescription at drug stores, convenience stores and grocery stores, as well as online.
  • "Today's approval marks the first time a nonprescription daily oral contraceptive will be an available option for millions of people in the United States," said Patrizia Cavazzoni, M.D., director of the FDA's Center for Drug Evaluation and Research.
  • "When used as directed, daily oral contraception is safe and is expected to be more effective than currently available nonprescription contraceptive methods in preventing unintended pregnancy."
  • Opill also should not be used together with another hormonal birth control product such as another oral contraceptive tablet, a vaginal ring, a contraceptive patch, a contraceptive implant, a contraceptive injection or an IUD (intra-uterine device).

Using Doxy to Prevent STIs Warrants Caution

Retrieved on: 
Wednesday, July 12, 2023
AIDS, Public Policy, Government, Health, Infectious Diseases, Advocacy Group Opinion, Pharmaceutical, Post-exposure prophylaxis, Gonorrhea, AHF, PEP, HIV, STI, Press release, Tetracycline, Public, Infection, Condom, NIH, Centers for Disease Control and Prevention, Doxycycline, National Institutes of Health, CDC, IG, AIDS Healthcare Foundation, Risk, Korea Disease Control and Prevention Agency, City, Vaccine, Antibiotics

“We ignore the risk of rising antibiotic resistance at great peril to global public health,” said Michael Weinstein, AHF’s president and cofounder.

Key Points: 
  • “We ignore the risk of rising antibiotic resistance at great peril to global public health,” said Michael Weinstein, AHF’s president and cofounder.
  • “We already are facing perilous drug resistance for gonorrhea treatments.
  • Condoms remain the most effective means of preventing STIs.”
    [1] National Institutes of Health.
  • To learn more about AHF, please visit our website , find us on Facebook , follow us on IG and Twitter , or subscribe to our “AHFter Hours” podcast.

IDENTIFYSENSORS BIOLOGICS ANNOUNCES NEW CLINICAL STUDIES GROUP TO VALIDATE DIGITAL DIAGNOSTIC DEVICES

Retrieved on: 
Wednesday, June 28, 2023
Norovirus, Rotavirus, HIV, Virology, SARS-CoV-2, Methicillin-resistant Staphylococcus aureus, Infection, Gonorrhea, Respiratory syncytial virus, Sale, Trial of the century, Hepatitis C, Chlamydia, B cell, FDA, Medeiros, PCR, Saliva, Medical device, Vaccine

CLEVELAND, June 28, 2023 /PRNewswire/ -- IdentifySensors® Biologics, a leading developer of digital diagnostic technologies, announces the formation of the company's new Clinical Studies Group, responsible for testing new diagnostic devices in preparation for FDA submissions.

Key Points: 
  • CLEVELAND, June 28, 2023 /PRNewswire/ -- IdentifySensors® Biologics, a leading developer of digital diagnostic technologies, announces the formation of the company's new Clinical Studies Group, responsible for testing new diagnostic devices in preparation for FDA submissions.
  • The group has started preparing for an extensive clinical study this fall of two multiplex respiratory devices intended to detect and differentiate SARS-CoV-2, Influenza A, Influenza B and respiratory syncytial virus in saliva.
  • The devices are intended to reduce costs and testing time, while increasing sensitivity and flexibility for clinicians and consumers.
  • "In preliminary studies we have seen encouraging results of this new technology," said Greg Hummer M.D., IdentifySensors® co-founder and CEO.

Exploding STI Rates Need Attention Now

Retrieved on: 
Saturday, June 24, 2023
AIDS, Public Policy, Government, Health, State, Local, Infectious Diseases, Advocacy Group Opinion, Los Angeles County Board of Supervisors, AHF, HIV, STI, Weeping Angel, L.A, Los Angeles County Department of Public Health, Public, Gonorrhea, Multimedia, STD, CDC, Public health, AIDS Healthcare Foundation, LA, Syphilis, Hotel

Because sexually transmitted infection (STI) rates continue to skyrocket in Los Angeles County and officials are dragging their feet on allocating resources to address the crisis, AIDS Healthcare Foundation (AHF), the world’s largest HIV healthcare provider, will protest, march, and testify on Monday, June 26th.

Key Points: 
  • Because sexually transmitted infection (STI) rates continue to skyrocket in Los Angeles County and officials are dragging their feet on allocating resources to address the crisis, AIDS Healthcare Foundation (AHF), the world’s largest HIV healthcare provider, will protest, march, and testify on Monday, June 26th.
  • AHF is calling on the Los Angeles County Department of Public Health and the County Board of Supervisors to do more to stop the spread of STIs.
  • A corresponding full-page advertisement in the Los Angeles Times will run on Sunday, June 25th, showing LA County has been “AWOL on STDs” and must act now.
  • To view AHF’s “STI Action Timeline” click here .

Simple HealthKit Launches At-Home Testing Kits on Walmart.com

Retrieved on: 
Monday, June 12, 2023
Gonorrhea, Type 2 diabetes, Wellness, Pharmacy, RI, Walmart, Quality of life, Health (Apple), Chlamydia, USPS, RSV, Trichomoniasis, Health, Diabetes, Glycated hemoglobin, Medical device

Simple HealthKit’s HbA1c (Diabetes) Tests identify key markers for Type 2 diabetes.

Key Points: 
  • Simple HealthKit’s HbA1c (Diabetes) Tests identify key markers for Type 2 diabetes.
  • “Early detection of health conditions can change an individual’s course and quality of life,” said Dr. Sheena Menezes, co-founder and CEO of Simple HealthKit.
  • Customers order the test with physician oversight, perform the test collection at home and send their sample via USPS to a Simple HealthKit lab.
  • “Simple HealthKit helps the patient bridge the gap between the test result and follow-up care.”
    In addition to working with retailers such as Walmart, Simple HealthKit works with pharmacies, educational institutions, employers and public health organizations to expand access to diagnostics in underserved communities.

Gonorrhoea and syphilis diagnoses are at their highest in decades – here's what you need to know about these STIs

Retrieved on: 
Saturday, June 10, 2023
Infection, Vagina, UK Health Security Agency, Pelvic inflammatory disease, Neisseria gonorrhoeae, Penis, STI, Syphilis, Deafness, Fever, Urethra, Congenital syphilis, Skin, Incontinence, Woman, Paratriathlon, Prostate, Abdominal pain, DSM-IV codes, Partner (business rank), Gonorrhea, Pain, Treponema pallidum, Man, Dementia, Time, Vaginal discharge, Risk, Child, Chronic pain, Security agency, Ulcer, Stillbirth, Chlamydia, Water, Ageing, Pregnancy, Diagnosis, Condom, Disease, Pharmaceutical industry, Birth control, Antibiotics, Treponema

Shockingly, gonorrhoea rates are the highest they have been since records began in 1918.

Key Points: 
  • Shockingly, gonorrhoea rates are the highest they have been since records began in 1918.
  • Gonorrhoea has increased from 71,133 diagnoses per year before the pandemic to 82,592 in 2022.
  • Syphilis, which in the early 2000s was almost non-existent in the UK, has increased to 8,692 diagnoses in 2022.

What symptoms do they cause?

    • In women symptoms can be less obvious, but include a watery, green, yellow or sometimes bloodstained vaginal discharge, and pain when urinating.
    • Symptoms include fever and abdominal pain.
    • For this reason, it’s essential to get diagnosed and treated if you’re experiencing any symptoms.
    • The disease now enters a latent phase where it stays in the body while showing no symptoms.
    • This causes a range of symptoms which were dreaded in the years before effective treatment – including skin and bone disfigurations, nerve pain, heart problems, deafness, blindness, dementia and other neurological symptoms such as difficulty walking and incontinence.

Why have rates increased?

    • It’s not entirely clear why rates of syphilis and gonorrhoea have increased so rapidly in the UK.
    • Data shows that rates of gonorrhoea in particular are sensitive to social and political change, including changes to funding for sexual health services.

What can I do to protect myself?

    • If you have a symptom you’re worried about, get it checked.
    • Self-test kits for gonorrhoea and syphilis are available online in some areas or you can go to a sexual health clinic if you prefer.

Antibiotic Overuse a Slippery Slope for STI Prevention, says AHF

Retrieved on: 
Tuesday, June 6, 2023
Infectious Diseases, Advocacy Group Opinion, Public Policy, Government, Healthcare Reform, Biotechnology, AIDS, White House, Federal Government, Health, Pharmaceutical, Post-exposure prophylaxis, AHF, Chlamydia, Condom, Drug resistance, STI, Gonorrhea, AIDS Healthcare Foundation, AMR, Syphilis, European, Birth control, Vaccine

AIDS Healthcare Foundation (AHF) welcomes the decision by the European Union to reduce antimicrobial resistance (AMR) by 20% in the bloc by 2030.

Key Points: 
  • AIDS Healthcare Foundation (AHF) welcomes the decision by the European Union to reduce antimicrobial resistance (AMR) by 20% in the bloc by 2030.
  • As part of the push, the strategy should discourage widespread use of pre- and post-exposure prophylaxis as the primary method of prevention for sexually transmitted infections (STI) in favor of promoting consistent condom use.
  • “Wealthy countries are courting another public health disaster by abandoning condoms and shifting STI prevention to bio-medical interventions.
  • If conventional drugs begin to fail on a population level, these once common, treatable bacteria might turn into deadly diseases,” said AHF President Michael Weinstein.

AHF Demands LA County Step Up to Stem STIs

Retrieved on: 
Tuesday, June 6, 2023
Infectious Diseases, Advocacy Group Opinion, Communications, Public Policy, Government, Philanthropy, AIDS, State, Local, Social Activism, Health, Foundation, Los Angeles County Board of Supervisors, AHF, Federation, HIV, STI, L.A, Los Angeles County Department of Public Health, Public, Gonorrhea, Federal, History, CDC, Public health, AIDS Healthcare Foundation, Syphilis, County

Tuesday, June 6th at 9 a.m.

Key Points: 
  • Tuesday, June 6th at 9 a.m.
    313 N. Figueroa St. (corner Temple St.) Los Angeles, CA 90012
    Kenneth Hahn Hall of Administration/L.A.
  • However, no new funding has come into the County as STI rates continue to climb,” said Alex Goncalves, Senior Director, AHF’s Public Health Division.
  • “So, we will protest, march, and speak out to demand stepped up action on STIs, be it pulling money from other budgets to support STIs or lobbying the Federal government for more funding.
  • Five years of unmet promises is too long for the County to say they will do more for STIs while nothing changes.”
    AHF’s Public Health Division created a one-sheet reference guide on the Board of Supervisors and L.A. County’s Department of Public Health’s actions on STIs.